Amicus Therapeutics (FOLD) Sees IPO Pricing Between $14-16 Per Share

May 17, 2007 8:36 AM EDT Send to a Friend
Amicus Therapeutics (Nasdaq: FOLD) has filed an amended S-1 statement with the SEC. The Company expects the public offering price to be between $14.00-16.00 per share. The Company is offering 5.0 million shares. The company plans to list on the Nasdaq Global Market under the symbol "FOLD".

The offering is being made through JPMorgan, Morgan Stanley, Merrill Lynch, Lazard Capital and Pacific Growth Equities.

Amicus Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule, orally-administered drugs, known as pharmacological chaperones, for the treatment of a range of human genetic diseases.

You May Also Be Interested In





Related Categories

IPOs

Add Your Comment